NCPDP Issues Oral Liquid Medications Industry Guidance

By: | Apr-15-14

<p><a href="https://www.ncpdp.org/">NCPDP</a>, the not-for-profit pharmacy standards development&nbsp;organization, recently announced the availability of a patient safety white <a href="http://ncpdp.org/Education/Whitepaper">paper</a> that provides specific&nbsp;industry guidance for standardizing the dosing designations and labeling of oral liquid medications. The&nbsp;white paper details patient risks associated with the variety of oral liquid dosing designations,&nbsp;prescribing practices and processing systems which can lead to dispensing and later administration&nbsp;errors that can harm patients–especially pediatric patients who are often prescribed liquid medications.&nbsp;</p>
<p>NCPDP&rsquo;s white paper provides best practice guidance on prescription orders, prescription labeling and&nbsp;administration of oral liquid medications. The recommendations are consistent with best practice&nbsp;requirements by The Joint Commission for certification across acute care inpatient settings, as well as the&nbsp;Food and Drug Administration and industry recommendations for over-the-counter&nbsp;medicines. The white paper also covers the provision and use of appropriate dosing devices, as well as&nbsp;recommendations for caregiver and patient education to facilitate proper administration of oral liquid&nbsp;medications. &nbsp;<br />
<br />
The white paper includes specific calls-to-action for industry stakeholders, but broadly calls organizations&nbsp;to communicate, adopt and implement the recommendations; measure organization performance and&nbsp;stress accountability across the organization for adhering to the recommendations; and develop patient-centered communications and encourage pharmacist-to-patient conversations at the point of&nbsp;dispensing.</p>

2016-12-06T13:24:32+00:00Apr-15-14|Categories: Article|Tags: , , |